Abstract:In esophageal adenocarcinoma, the presence of lymph node metastases predicts patients' survival even after curative resection. Currently, there is no highly accurate marker for detecting the presence of lymph node metastasis. The SEMA3F/NRP2 axis was initially characterized in axon guidance and recent evidence has revealed its significant involvement in lymphangiogenesis, angiogenesis, and carcinogenesis. Hence, the objective of this study was to elucidate the roles of SEMA3F and its receptor NRP2 in esophageal adenocarcinoma. We conducted an immunohistochemical evaluation of SEMA3F and NRP2 protein expression in 776 patients with esophageal adenocarcinoma who underwent Ivor-Lewis esophagectomy at the University Hospital of Cologne. Total and positive cancer cell counts were digitally analyzed using QuPath and verified by experienced pathologists to ensure accuracy. Positive expression was determined as a cell percentage exceeding the 50th percentile threshold. In our cohort, patients exhibiting SEMA3F positive expression experience significantly lower pT- and pN-stages. In contrast, positive NRP2 expression is associated with the presence of lymph node metastases. Survival analyses showed that the expression status of NRP2 had no impact on patient survival. However, SEMA3F positivity was associated with a favorable patient survival outcome (median OS: 38.9 vs. 26.5 months). Furthermore, SEMA3F could be confirmed as an independent factor for better patient survival in patients with early tumor stage (pT1N0-3: HR = 0.505, p = 0.014, pT1-4N0: HR = 0.664, p = 0.024, pT1N0: HR = 0.483, p = 0.040). In summary, SEMA3F emerges as an independent predictor for a favorable prognosis in patients with early-stage esophageal adenocarcinoma. Additionally, NRP2 expression is linked to a higher risk of lymph node metastases occurrence. We hypothesize that low SEMA3F expression could identify patients with early-stage tumors who might benefit from more aggressive treatment options or intensified follow-up. Furthermore, SEMA3F and its associated pathways should be explored as potential tumor-suppressing agents.

Semaphorin-3F is an Immune Suppressor, not a Tumor Suppressor, in Oral Carcinogenesis

Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.

SEMA3G-NRP1 Signaling Functions as an Immune Checkpoint that Enables Tumor Immune Evasion by Impairing T Cell Cytotoxicity.

Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

Expression of Semaphorin 3c in Breast Cancer and Its Impact on Adhesion and Invasion of Breast Cancer Cells

Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice

Ncrnas-Mediated High Expression of SEMA3F Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma

Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma

Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models.

Semaphorin3F down-regulates the expression of integrin α vβ3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro

SEMA3F Prevents Metastasis of Colorectal Cancer by PI3K–AKT‐dependent Down‐regulation of the ASCL2–CXCR4 Axis

Epigenetically Downregulated Semaphorin 3E Contributes to Gastric Cancer.

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis

Semaphorin-3F Suppresses the Stemness of Colorectal Cancer Cells by Inactivating Rac1.

Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma

Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.

The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma

Downregulation of Semaphorin-3F is Associated with Poor Prognostic Significance in Osteosarcoma Patients.

Sema3A chemorepellant regulates the timing and patterning of dental nerves during development of incisor tooth germ

Semaphorin 3F Induces Colorectal Cancer Cell Chemosensitivity by Promoting P27 Nuclear Export